CD44 and neoplasm: When we purified out CD44+/CD44− and α2β1+/α2β1− LAPC4 cells from the xenografts and performed similar LDA tumor experiments, surprisingly, the marker-positive and marker-negative subpopulations appeared similarly tumorigenic (Table 2).